Academic Journals Database
Disseminating quality controlled scientific knowledge

PHARMACOTHERAPY BASED PROBLEMS WITH THE RECENT ADVANCES IN THE MANAGEMENT OF DIABETIS MELLITUS

ADD TO MY LIST
 
Author(s): NAVEEN KUMAR . T | L.NAGAKRISHNA | LAKHAVAT SUDHAKAR | ANURAG THATIPALLI

Journal: Mintage Journal of Pharmaceutical and Medical Sciences
ISSN 2320-3315

Volume: 2;
Issue: 3;
Start page: 5;
Date: 2013;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: GLP-1 Mimetics | DPP-4 Inhibitors | SGLT-2 Inhibitors | Amylin Mimetics | Lispro insulin | Isophane insulin | Glargine insulin

ABSTRACT
Objectives : To review the drug treatments and some of the popular , non traditional remedies now available for type-2 diabetis mellitus, as well as selected investigational agents , to describe each medications place in the overal approach to treatment.Material and Methods : Data source from english language journals, pharmacolgy text books, abstracts, review articles and news paper accounts.Results :Older drugs like Sulfonyl ureas and Meglinitide analogues stimulate production and release of insulin.These drugs must be used in patients with intact pancreas and are associated with risk of hypoglycaemic .Biguanides (metformin) reduces hepatic glucose production and increases peripheral glucose utilization, but its use is hampered by a high percentage of adverse reaction like metallic taste and diarrhoea.Thiazolidinediones induce PPARץ which express relevant genes increase glucose transport and utilization.but the disadvantage is increased risk of cardiovascular problems.£ -glucosidase inhibitors inhibit enzymes £ -glucosidases present in the intestinal brush borders and there by prevent the absorption and delay the digestion of carbohydrates .Abdominal distension and diarrhea had restricted their use.Conclusion :. Hence there is continuous ongoing work in development of newer drugs ,which are safe ,efficacious and potent as well as free of undesirable effects such as sustained hypoglycemia. Fortunately there are newer drug , few of them approved while other still knocking the door from the classes of drug such as GLP1 Mimetic ,DPP-4 Inhibitors, SGLT-2 Inhibitors , insulin new class of drugs. Here we have tried to cover adverse effects and pharmacotherapy based problems in brief.
Why do you need a reservation system?      Affiliate Program